Unknown

Dataset Information

0

Xenogeneic Decellularized Scaffold: A Novel Platform for Ovary Regeneration.


ABSTRACT: Women younger than 40 years may face early menopause because of premature ovarian failure (POF). The cause of POF can be idiopathic or iatrogenic, especially the cancer-induced oophorectomy and chemo- or radiation therapy. The current treatments, including hormone replacement therapy (HRT) and cryopreservation techniques, have increased risk of ovarian cancer and may reintroduce malignant cells after autografting. Decellularization technique has been regarded as a novel regenerative medicine strategy for organ replacement, wherein the living cells of an organ are removed, leaving the extracellular matrix (ECM) for cellular seeding. This study aimed to produce a xenogeneic decellularized ovary (D-ovary) scaffold as a platform for ovary regeneration and transplantation. We have developed a novel decellularization protocol for porcine ovary by treatment with physical, chemical, and enzymatic methods. Using hematoxylin and eosin (H&E) staining, DAPI staining, scanning electron microscopy (SEM), and quantitative analysis, this approach proved effective in removing cellular components and preserving ECM. Furthermore, the results of biological safety evaluation demonstrated that the D-ovary tissues were noncytotoxic for rat ovarian cells in vitro and caused only a minimal immunogenic response in vivo. In addition, the D-ovary tissues successfully supported rat granulosa cell penetration ex vivo and showed an improvement in estradiol (E2) hormone secretion.

SUBMITTER: Liu WY 

PROVIDER: S-EPMC5315000 | biostudies-literature | 2017 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Xenogeneic Decellularized Scaffold: A Novel Platform for Ovary Regeneration.

Liu Wen-Yue WY   Lin Shi-Gang SG   Zhuo Ru-Yi RY   Xie Yuan-Yuan YY   Pan Wei W   Lin Xian-Feng XF   Shen Fei-Xia FX  

Tissue engineering. Part C, Methods 20170110 2


Women younger than 40 years may face early menopause because of premature ovarian failure (POF). The cause of POF can be idiopathic or iatrogenic, especially the cancer-induced oophorectomy and chemo- or radiation therapy. The current treatments, including hormone replacement therapy (HRT) and cryopreservation techniques, have increased risk of ovarian cancer and may reintroduce malignant cells after autografting. Decellularization technique has been regarded as a novel regenerative medicine str  ...[more]

Similar Datasets

| S-EPMC4734393 | biostudies-literature
| S-EPMC7099865 | biostudies-literature
| S-EPMC6439446 | biostudies-literature
| S-EPMC3031749 | biostudies-literature
| S-EPMC4350019 | biostudies-literature
| S-EPMC4670224 | biostudies-literature
| S-EPMC5453498 | biostudies-literature
| S-EPMC5434867 | biostudies-literature
| S-EPMC3483066 | biostudies-literature
| S-EPMC8706177 | biostudies-literature